UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 03/2008, Volume 358, Issue 11, pp. 1160 - 1174
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 4, pp. 317 - 327
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Maintenance Chemotherapy - adverse effects | Pancreatic Neoplasms - drug therapy | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Adenocarcinoma - genetics | Pancreatic Neoplasms - mortality | Genes, BRCA1 | Double-Blind Method | Pancreatic Neoplasms - pathology | Kaplan-Meier Estimate | Pancreatic Neoplasms - genetics | Piperazines - therapeutic use | Adenocarcinoma - drug therapy | Piperazines - adverse effects | Adenocarcinoma - secondary | Phthalazines - therapeutic use | Progression-Free Survival | Aged | Phthalazines - adverse effects | Adenocarcinoma - mortality | Genetic aspects | Research | Drug therapy | BRCA mutations | Pancreatic cancer | Intervention | BRCA2 protein | Adenosine | Medical imaging | Tablets | BRCA1 protein | Poly(ADP-ribose) polymerase | Breast cancer | Metastasis | Cancer therapies | Survival | Metastases | Ovarian cancer | Quality of life | Chemotherapy | Ribose | Platinum | Antitumor activity | Mutation | Health risk assessment | Deoxyribonucleic acid--DNA | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2001, Volume 7, Issue 10, pp. 2958 - 2970
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - immunology | Antineoplastic Agents - immunology | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Antibodies, Monoclonal, Humanized | Animals | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cetuximab | Antibodies, Monoclonal - immunology | Index Medicus
Journal Article
4.
Full Text
Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma
The lancet oncology, ISSN 1470-2045, 02/2019, Volume 20, Issue 2, pp. e124 - e124
Journal Article
Current pharmaceutical design, ISSN 1381-6128, 03/2014, Volume 20, Issue 42, pp. 6660 - 6669
FOLFIRINOX | Pancreatic cancer | Combination therapies | Hypoxia | TGF-β | Drug resistance | Nab-paclitaxel | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pancreatic Neoplasms - drug therapy | Pancreatic Neoplasms - metabolism | Drug Therapy, Combination | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Pancreatic Neoplasms - pathology
Journal Article
Nature (London), ISSN 0028-0836, 03/2016, Volume 531, Issue 7592, pp. 47 - 52
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Pancreatic Neoplasms - metabolism | Prognosis | Hepatocyte Nuclear Factor 3-beta - genetics | Genomics | Humans | Carcinoma, Pancreatic Ductal - metabolism | Gene Expression Regulation, Neoplastic | Transcriptome | Hepatocyte Nuclear Factor 3-gamma - genetics | Gene Regulatory Networks | Histone Demethylases - genetics | Tumor Suppressor Protein p53 - genetics | Carcinoma, Pancreatic Ductal - genetics | DNA Methylation | Tumor Suppressor Proteins - genetics | Carcinoma, Pancreatic Ductal - classification | Trans-Activators - genetics | Pancreatic Neoplasms - classification | Transcription, Genetic | Nuclear Proteins - genetics | Carcinoma, Pancreatic Ductal - immunology | Genes, Neoplasm - genetics | Basic Helix-Loop-Helix Transcription Factors - genetics | Pancreatic Neoplasms - pathology | Zebrafish Proteins | Pancreatic Neoplasms - genetics | Receptors, Cytoplasmic and Nuclear - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Mutation - genetics | Carcinoma, Pancreatic Ductal - pathology | Genome, Human - genetics | Homeodomain Proteins - genetics | Animals | Pancreatic Neoplasms - immunology | Survival Analysis | Cell Line, Tumor | Mice | Physiological aspects | Pancreatic cancer | Methods | Genes | Genomes | Mutation | Gene expression | Tumors | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 09/2020, Volume 136, pp. 195 - 203
Sarcomatoid RCC | Renal cell carcinoma | Immune checkpoint inhibitor combinations | Immunotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Renal cell | Health services | Clinical trials | Survival | Patients | Confidence intervals | Heterogeneity | Angiogenesis | Immune checkpoint | Antiangiogenics | Medical prognosis | Kidney cancer | Risk management | Clear cell-type renal cell carcinoma | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 02/2015, Volume 518, Issue 7540, pp. 495 - 501
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Genomics | Humans | DNA Repair - genetics | Carcinoma, Pancreatic Ductal - genetics | Pancreatic Neoplasms - drug therapy | Point Mutation - genetics | DNA Mutational Analysis | Genes, BRCA2 | Pancreatic Neoplasms - classification | Female | Adenocarcinoma - genetics | Genes, BRCA1 | Platinum - pharmacology | Genomic Instability - genetics | Genotype | Pancreatic Neoplasms - genetics | Mutation - genetics | Adenocarcinoma - drug therapy | Poly(ADP-ribose) Polymerase Inhibitors | Genome, Human - genetics | Xenograft Model Antitumor Assays | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Genetic Markers - genetics | Mice | Copy number variations | Pancreatic cancer | Physiological aspects | Development and progression | Genetic aspects | Research | Tumor proteins | Risk factors | Genes | DNA damage | Clinical trials | Genomes | Cancer therapies | Patients | Biomarkers | Mutation | Chromosomes | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 12/2013, Volume 45, Issue 12, pp. 1470 - 1473